Arcutis Biotherapeutics Stock Performance
as on August 20, 2026 at 2:16 pm IST
Day's Low
Day's High
$26.38$27.15
0.30%
Downside
2.61%
Upside
52 Week's Low
52 Week's High
$15.10$31.7742.93%
Downside
20.07%
Upside
Arcutis Biotherapeutics share price movements today
- Previous Close
- $26.54
- Open
- $27.14
- Volume
- 526.5K
- Market Cap
- $3.3B
- Day's Low - High
- $26.38 - $27.15
- 52 Week Low - High
- $15.10 - $31.77
Arcutis Biotherapeutics Historical Returns
- 1 Month Return
- -8.07 %
- 3 Month Return
- + 22.84 %
- 1 Year Return
- + 55.06 %
- 3 Year Return
- + 222.54 %
- 5 Year Return
- + 33.55 %
Arcutis Biotherapeutics Stock Fundamentals & Key Indicators
Check Arcutis Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.3B
EPS (TTM)
0.2227
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
116.98
Industry PE ratio
-13.046547619047619
PEG Ratio
0.019146002911236398
EBITDA
44.1M
Revenue (TTM)
464.0M
Profit Margin
91.14%
Return On Equity TTM
15.05%
Arcutis Biotherapeutics Stock Valuation
Track how Arcutis Biotherapeutics P/E has moved over time to understand its valuation trends.
Arcutis Biotherapeutics in the last 5 years
Lowest (-223.38x)
December 31, 2025
Today (-223.38x)
December 31, 2025
Industry (-13.05x)
December 31, 2025
Highest (-0.85x)
December 31, 2023
Today’s Price to Earnings Ratio: -223.38x
Arcutis Biotherapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Arcutis Biotherapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $3.3B | 33.55% | 116.98 | 91.14% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for Arcutis Biotherapeutics Stock including INR - Dollar returns
The Arcutis Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Arcutis Biotherapeutics investment value today
Current value as on today
₹1,72,282
Returns
₹72,282
(+72.28%)
Returns from Arcutis Biotherapeutics Stock
₹56,661 (+56.66%)
Dollar Impact
₹15,621 (+15.62%)
Analyst Recommendation on Arcutis Biotherapeutics Stock
Based on 7 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Arcutis Biotherapeutics. Average target price of $36.88
Arcutis Biotherapeutics Share Price Target
Get share price movements and forecasts by analysts on Arcutis Biotherapeutics.
What analysts predicted
28.25%UPSIDE
Target Price
$36.88
Current Price
$26.46
Analyzed by
7 Analysts
Target
$36.88
Arcutis Biotherapeutics target price $36.88, a slight upside of 28.25% compared to current price of $26.46. According to 7 analysts rating.
Indian Investors' Interest in Arcutis Biotherapeutics Stock
Search interest for Arcutis Biotherapeutics Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:11% versus previous 30 day period
Arcutis Biotherapeutics Quarterly Profit & Loss
All numbers in Millions USD
Arcutis Biotherapeutics Annual Profit & Loss
All numbers in Millions USD
Arcutis Biotherapeutics Quarterly Cash Flow
All numbers in Millions USD
Arcutis Biotherapeutics Annual Cash Flow
All numbers in Millions USD
Arcutis Biotherapeutics News & Key Events
Today's Timeline - 17 December
Wed, 10:30 PM
-Arcutis Biotherapeutics reports strong performance of Zoryve, boosting sales through consistent label expansion.
Thu, 04:28 AM
-Insider sold shares worth $332,851, according to a recent SEC filing.
Insights on Arcutis Biotherapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 105.39M → 129.86M (in $), with an average increase of 18.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 years, ARQT stock has moved up by 238.4%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -11.29M → 15.00M (in $), with an average increase of 175.3% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 624.7% return, outperforming this stock by 386.3%
- NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.6% return, outperforming this stock by 426.0%
About Arcutis Biotherapeutics
| Organisation | Arcutis Biotherapeutics |
| Headquarters | 3027 Townsgate Road, Westlake Village, CA, United States, 91361 |
| Industry | Biotechnology |
| CEO | Mr. Todd Franklin Watanabe M.A. |
| E-voting on shares | Click here to vote |
Key Management of Arcutis Biotherapeutics
Name | Title |
|---|---|
Mr. Brian Schoelkopf | Head of Investor Relations |
Ms. Amanda Sheldon | Head of Corporate Communications |
Ms. Aleen Hosdaghian | Vice President of Marketing |
Mr. Todd Franklin Watanabe M.A. | President, CEO & Director |
Mr. Masaru Matsuda Esq., J.D. | Executive VP, Chief Legal Officer & Corporate Secretary |
Dr. Patrick E. Burnett M.D., Ph.D. | Executive VP & Chief Medical Officer |
Mr. Steve Arias | Vice President of Compliance & Privacy |
Dr. Bhaskar Chaudhuri Ph.D. | Co-Founder & Director Emeritus |
Ms. Latha Vairavan | Senior VP & Chief Financial Officer |
Mr. Larry Todd Edwards | Executive VP & Chief Commercial Officer |
FAQs
What is Arcutis Biotherapeutics share price today?
Arcutis Biotherapeutics share price today is $26.46 as on at the close of the market. Arcutis Biotherapeutics share today touched a day high of $27.15 and a low of $26.38.
What is the 52 week high and 52 week low for Arcutis Biotherapeutics share?
Arcutis Biotherapeutics share touched a 52 week high of $31.77 on and a 52 week low of $15.10 on . Arcutis Biotherapeutics stock price today i.e. is closed at $26.46,which is 16.71% down from its 52 week high and 75.23% up from its 52 week low.
What is Arcutis Biotherapeutics's market capitalisation today?
Arcutis Biotherapeutics market capitalisation is $0.00T as on .
How to invest in Arcutis Biotherapeutics Stock (ARQT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Arcutis Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcutis Biotherapeutics Shares that will get you 0.0567 shares as per Arcutis Biotherapeutics share price of $26.46 per share as on August 20, 2026 at 8:46 am IST.
What is the minimum amount required to buy Arcutis Biotherapeutics Stock (ARQT) from India?
Indian investors can start investing in Arcutis Biotherapeutics (ARQT) shares with as little as ₹95.695 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.95 in Arcutis Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arcutis Biotherapeutics share’s latest price of $26.46 as on August 20, 2026 at 8:46 am IST, you will get 0.3779 shares of Arcutis Biotherapeutics. Learn more about
fractional shares .
What are the returns that Arcutis Biotherapeutics has given to Indian investors in the last 5 years?
Arcutis Biotherapeutics stock has given 33.55% share price returns and 28.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?